Medical Service Utilization and Direct Medical Cost of Stroke in Urban China

Document Type: Original Article

Authors

1 China Center for Health Development Studies, Peking University, Beijing, China

2 School of Management, Beijing University of Chinese Medicine, Beijing, China

3 National Institute of Chinese Medicine Development and Strategy, Beijing University of Chinese Medicine, Beijing, China

4 School of Economics and School of Management, Tianjin Normal University, Tianjin, China

5 Australian National Institute of Management and Commerce, Sydney, NSW, Australia

6 Research Institute for International Strategies, Guangdong University of Foreign Studies, Guangzhou, China

7 Newcastle Business School, University of Newcastle, Newcastle, NSW, Australia

8 School of Public Health, Peking University, Beijing, China

9 Institute of Population Research, Peking University, Beijing, China

10 China Health Insurance Research Association, Beijing, China

Abstract

Background
Understanding the treatment costs of stroke can guide health policies and interventions. However, few studies have analyzed the treatment costs of stroke in China. The aim of this study is to assess stroke-related medical service utilization, direct costs of stroke and associated stroke predictors, and, second, to understand the structure of medical resource use.
 
Methods
This study used a 5% random sample of claim data from China’s Urban Basic Medical Insurance between January 2013 to December 2016. The sampling design assigned a sample weight to each beneficiary. Weighted descriptive analyses, Poisson regression and generalized linear model were used to analyze the medical service utilization, costs and their associations with patient characteristics.
 
Results
In urban China, the annual prevalence of stroke was 730.43 (95% CI = 730.10-730.76) cases per 100 000 people, and nearly 2% of total health expenditures of urban residents was spent on stroke-related medical costs. Weighted average annual total medical cost of stroke was RMB10 637 [95% CI = 10 435-10 840] (US$1682, 95% CI = 1650-1714), with annual out-of-pocket (OOP) cost of RMB3093 [95% CI = 3026-3161] (US$489, 95% CI = 478-500). The average yearly number of stroke-related outpatient visit was 1.67 [SD = 3.39] and inpatient admission was 0.79 [SD = 0.83], with an average cost of RMB440 [SD = 739] (US$70, SD = 117) for outpatients and RMB12 702 [SD = 21 424] (US$2008, SD = 3387) for inpatients. Inpatient costs accounted for 94% (RMB10 034 or US$ 1586) of medical costs, and tertiary hospitals were the main provider of stroke care. Stroke-related medical care utilization and direct costs were associated with gender, age, pathological stroke types and insurance status. Medication costs contributed to 50.6% (RMB5382 or US$ 851) of the average stroke-related medical costs.
 
Conclusion
China’s health system bares a large economic burden from stroke. Specific policies are needed to strengthen the capacity of secondary hospitals, alter the structure of medical resource allocation, and target specific sections of the stroke population.

Highlights

 

Supplementary File 1 (Download)

 

Keywords


  1. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-1210. doi:10.1016/s0140-6736(17)32152-9
  2. Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA. International comparison of stroke cost studies. Stroke. 2004;35(5):1209-1215. doi:10.1161/01.str.0000125860.48180.48
  3. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-1623. doi:10.1016/s0140-6736(08)60694-7
  4. Saka Ö, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing. 2009;38(1):27-32. doi:10.1093/ageing/afn281
  5. Chevreul K, Durand-Zaleski I, Gouépo A, Fery-Lemonnier E, Hommel M, Woimant F. Cost of stroke in France. Eur J Neurol. 2013;20(7):1094-1100. doi:10.1111/ene.12143
  6. Hodgson TA, Cohen AJ. Medical expenditures for major diseases, 1995. Health Care Financ Rev. 1999;21(2):119-164.
  7. Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient-level data: a critical review of the literature. Stroke. 2009;40(2):e18-23. doi:10.1161/strokeaha.108.529776
  8. Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759-771. doi:10.1161/circulationaha.116.025250
  9. Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394-405. doi:10.1016/s1474-4422(18)30500-3
  10. Guan T, Ma J, Li M, et al. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013. Neurology. 2017;89(1):53-61. doi:10.1212/wnl.0000000000004056
  11. Wang YL, Wu D, Liao X, Zhang W, Zhao X, Wang YJ. Burden of stroke in China. Int J Stroke. 2007;2(3):211-213. doi:10.1111/j.1747-4949.2007.00142.x
  12. Ma Y, Liu Y, Fu HM, et al. Evaluation of admission characteristics, hospital length of stay and costs for cerebral infarction in a medium-sized city in China. Eur J Neurol. 2010;17(10):1270-1276. doi:10.1111/j.1468-1331.2010.03007.x
  13. Yin X, Huang L, Man X, et al. Inpatient cost of stroke in Beijing: a descriptive analysis. Neuroepidemiology. 2018;51(3-4):115-122. doi:10.1159/000491091
  14. Zhai T, Goss J, Li J. Main drivers of health expenditure growth in China: a decomposition analysis. BMC Health Serv Res. 2017;17(1):185. doi:10.1186/s12913-017-2119-1
  15. Zhang L, Wang H, Li Q, Zhao MH, Zhan QM. Big data and medical research in China. BMJ. 2018;360:j5910. doi:10.1136/bmj.j5910
  16. Fang H, Eggleston K, Hanson K, Wu M. Enhancing financial protection under China's social health insurance to achieve universal health coverage. BMJ. 2019;365:l2378. doi:10.1136/bmj.l2378
  17. Bagley SC, Altman RB. Computing disease incidence, prevalence and comorbidity from electronic medical records. J Biomed Inform. 2016;63:108-111. doi:10.1016/j.jbi.2016.08.005
  18. National Health and Family Planning Commission. China Health and Family Planning Yearbook. China Union Medical University Press; 2016.
  19. Rha JH, Koo J, Cho KH, et al. Two-year direct medical costs of stroke in Korea: a multi-centre incidence-based study from hospital perspectives. Int J Stroke. 2013;8(3):186-192. doi:10.1111/j.1747-4949.2012.00815.x
  20. Ng CS, Toh MP, Ng J, Ko Y. Direct medical cost of stroke in Singapore. Int J Stroke. 2015;10 Suppl A100:75-82. doi:10.1111/ijs.12576
  21. Hu S, Zhan L, Liu B, et al. Economic burden of individual suffering from atrial fibrillation-related stroke in China. Value Health Reg Issues. 2013;2(1):135-140. doi:10.1016/j.vhri.2013.02.008
  22. Brüggenjürgen B, Rossnagel K, Roll S, et al. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Value Health. 2007;10(2):137-143. doi:10.1111/j.1524-4733.2006.00160.x
  23. Chhabra M, Sharma A, Ajay KR, Rathore MS. Assessment of risk factors, cost of treatment, and therapy outcome in stroke patients: evidence from cross-sectional study. Expert Rev Pharmacoecon Outcomes Res. 2019;19(5):575-580. doi:10.1080/14737167.2019.1580574
  24. Kissela BM, Sauerbeck L, Woo D, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 2002;33(5):1321-1326. doi:10.1161/01.str.0000014773.57733.3e
  25. Dewey HM, Thrift AG, Mihalopoulos C, et al. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2001;32(10):2409-2416. doi:10.1161/hs1001.097222
  26. Fattore G, Torbica A, Susi A, et al. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 2012;12:137. doi:10.1186/1471-2377-12-137
  27. The World Bank. Deepening Health Reform in China: Building High-Quality and Value-Based Service Delivery - Policy Summary. Washington, DC: The World Bank; 2016.
  28. Wang G, Zhang Z, Ayala C, Dunet DO, Fang J, George MG. Costs of hospitalization for stroke patients aged 18-64 years in the United States. J Stroke Cerebrovasc Dis. 2014;23(5):861-868. doi:10.1016/j.jstrokecerebrovasdis.2013.07.017
  29. Yu H. Universal health insurance coverage for 1.3 billion people: what accounts for China's success? Health Policy. 2015;119(9):1145-1152. doi:10.1016/j.healthpol.2015.07.008
  30. Cha YJ. The economic burden of stroke based on South Korea's national health insurance claims database. Int J Health Policy Manag. 2018;7(10):904-909. doi:10.15171/ijhpm.2018.42
  31. Zhu D, Shi X, Nicholas S, Bai Q, He P. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study. BMJ Open. 2019;9(8):e029646. doi:10.1136/bmjopen-2019-029646
  32. Jin L. From mainstream to marginal? trends in the use of Chinese medicine in China from 1991 to 2004. Soc Sci Med. 2010;71(6):1063-1067. doi:10.1016/j.socscimed.2010.06.019
  33. Report on the informatization of Chinese hospitals, 2018. Association of Chinese Hospital Management; 2019.